Marko Topalovic
Founder of ArtiQ, now Chief AI Officer | Clario
Marko Topalovic is the founder of ArtiQ, a Leuven-based health AI company focused on respiratory medicine. ArtiQ develops AI-powered software that helps medical professionals diagnose, treat and monitor patients with lung diseases, and supports respiratory clinical trials by improving the interpretation and quality of pulmonary function data.
After ArtiQ was acquired by Clario, Marko continued to lead ArtiQ and took on a broader role in AI strategy within Clario. Clario is now part of Thermo Fisher Scientific.
In their session, Marko and Urbain Vandeurzen (Smile Invest) meet for a conversation about building health technology from Leuven, scaling internationally and understanding what really determines success when the product, the market and the patient reality are complex.
A line-up of human-centric innovators
These extraordinary technology experts know their way around the latest innovations, but they always keep in mind that we're extra ordinary first.
